From July 1, 2022 to September 30, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 590,751 shares, representing 4.15% for $30 million under the buyback announced on May 2, 2019.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.55 USD | +2.48% | +9.50% | +25.11% |
03-14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
03-13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.11% | 408M | |
-2.47% | 88.14B | |
+1.45% | 40.44B | |
-16.13% | 32.24B | |
+51.96% | 24.39B | |
-14.34% | 15.59B | |
-39.40% | 12.3B | |
-6.52% | 12.18B | |
-13.35% | 12.14B | |
+5.17% | 8.87B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Tranche Update on Anika Therapeutics, Inc.'s Equity Buyback Plan announced on May 2, 2019.